24Jun 25
The Mikara study opens up new perspectives for the treatment of rheumatoid arthritis
There Nutritional management of arthritis rheumatoid (AR) conquers a new space in clinical practice thanks to the results of the Mikara Studiopublished on Nutrients in 2023. The study, conducted by Claudia Heidt And colleagues, evaluated the effect of a nutritional intervention based on Medium chain triglycerides (MCT) and soluble/insoluble fiber in patients with AR, highlighting a significant improvement in the activity of the diseasemeasured through the index Sdai.
The Mikara studio, lasting 16 weeks and conducted in double blind with placebo, recorded An increase in beta-hydroxybutirrato levels (BHB)a ketone body with effects anti -inflammatory documented (Youum et al., Nature Medicine 2015), indicating a potential synergistic action between energy metabolism and inflammation control. The formulation used, Mikara Shakewas developed by Dr. Schär To respond specifically to the needs of patients with chronic pathologies.
“The value of the Mikara Studio – explains the Prof. Francesca IngegnoliRheumatologist at ASST Gaetano Pini Cto and teacher atUniversity of Milan – It is twofold: on the one hand it highlights the effectiveness of an integrated nutritional support for drug therapy; on the other, it offers a concrete opportunity to also face the metabolic and functional fragility of these patients “.
The fibers used, from bamboo And psilliumhave allowed the achievement of the recommended daily requirement, preventing deficiencies often present in rheumatic patients (Sir – Italian Society of Rheumatology). The added value? A formulation practice, accessible and well toleratedwhich helps patients a maintain autonomy, nutritional balance and therapeutic adhesion.
The Mikara Studio marks a step forward towards one personalized medicinewhich considers the Food as an active part of the treatmentnext to the drugs. For patients with AR, it can represent a concrete turning point in the quality of life.